Your Basket
0
You have no items in your shopping cart.

0

×

Registration

Profile Informations

Login Datas

or login

First name is required!
Last name is required!
First name is not valid!
Last name is not valid!
This is not an email address!
Email address is required!
This email is already registered!
Password is required!
Enter a valid password!
Please enter 6 or more characters!
Please enter 16 or less characters!
Passwords are not same!
Terms and Conditions are required!
Email or Password is wrong!

Juvederm - FAQ's

Juvederm

Frequently Asked Questions about Juvederm

Q: What is JUVEDERM?

A. Juvederm is a non-surgical, smooth consistency gel dermal filler that helps to instantly restore your skin's volume and smooth away facial wrinkles and folds like your deeper "smile lines". Juvederm temporarily adds volume to facial tissue and restores a smoother appearance to the face and is often used as a lip enhancement.

Q: How is JUVEDERM used?

A. Juvederm is injected into areas of facial tissue using a fine needle. Our skillful injector eases Juvederm under the skin to add facial volume and diminish the appearance of wrinkles, scars, and nasolabial folds instantly.

Q: How does JUVEDERM work?

A. While there are a variety of hyaluronic acid fillers, Juvederm is uniquely formulated. A next generation Hyaluronic Acid filler, Juvederm uses a manufacturing process called HYLACROSS™ technology. HYLACROSS™ gives Juvederm its special smooth-gel structure that holds up over time. That's why Juvederm is the first smooth-consistency HA gel and the only Hyaluronic Acid filler that is FDA approved to last up to one year with only one treatment.

More Frequently Asked Questions about Juvederm

Q: What is Hyaluronic Acid?

A. Hyaluronic Acid is a naturally occurring substance found in all mammals that helps to hydrate and add volume to your skin. In addition to its use as an aesthetic treatment, Hyaluronic Acid has also been used for more than 20 years for injection into arthritic joints to aid movement as well as for eye surgeries and wound repair.

Young, healthy-looking skin contains an abundance of naturally hydrating Hyaluronic Acid (HA). As you age, sunlight and other factors can reduce the amount of HA in your skin. The lack of HA causes your skin to lose structure and volume, creating unwanted facial wrinkles and folds - like those parentheses lines around your nose and mouth.

Using a dermal filler like Juvederm is a safe and effective way to replace the HA your skin has lost, bringing back its volume where your face needs it the most.

Q: What is cross-linked Hyaluronic Acid?

A. "Uncross-linked" Hyaluronic Acid in its natural form is in a liquid state. "Cross-linking" is the process through which hyaluronic acid is made into a gel product that can be injected into the skin for long-lasting results.

Q: What will treatment with JUVEDERM injectable gel accomplish?

A. Juvederm injectable gel will help to smooth moderate to severe facial wrinkles and folds. Most patients need one treatment to achieve optimal wrinkle smoothing, and one treatment could smooth your lines and wrinkles for up to one year. Ask our injector what you should expect from your initial treatment and when they would recommend rescheduling another appointment.

Q: What makes JUVEDERM different than other dermal fillers?

A. Juvederm is the ONLY Hyaluronic Acid (HA) filler FDA approved to last up to one year.* The unique manufacturing process provides a high concentration of cross-linked hyaluronic acid for long-lasting results. It also works to create a smooth consistency gel that flows easily into the skin and provides a smooth, natural look and feel. All other hyaluronic acid dermal fillers currently on the market are made of granular consistency gels. Juvederm is the first hyaluronic acid dermal filler that has demonstrated its safety and effectiveness in persons of color. Because Juvederm is the softest form of all the hyaluronic gels on the market, it is widely used for lip enhancement to achieve the most natural look and feel.

Q: Why does JUVEDERM come in two formulations?

A. Juvederm injectable gel is available in two formulations to allow your healthcare professional to tailor treatment to your unique needs. Juvederm Ultra provides versatility in contouring and volumizing facial wrinkles and folds. Juvederm Ultra Plus is a more robust formulation for volumizing and correcting deeper folds and wrinkles.

Q: How is JUVEDERM different than BOTOX cosmetic?

A. Juvederm injectable gel is a "next-generation" hyaluronic acid dermal filler that provides volume and is used to treat wrinkles and folds resulting from a loss of volume beneath the surface of the skin. Botox Cosmetic is not a filler. Botox Cosmetic relaxes muscle activity and is used to treat moderate to severe lines caused by facial expressions.

Q: When will I start to see results?

A. You will see a visible improvement immediately after treatment. Our injector will work with you on an individual basis to achieve the most desirable, natural looking results. The full results are gauged after about 10 days.

Q: How long will the results last?

A. Juvederm is the ONLY Hyaluronic Acid (HA) filler FDA approved to last up to one year. Most patients find that it is an annual treatment.

Q: Does the correction last forever?

A. No. Correction is temporary; therefore, touch-up injections as well as repeat injections are usually needed to maintain optimal long lasting results.

Q: What are the possible side effects of JUVEDERM?

A. Most side effects are mild or moderate in nature, and their duration is typically not long lasting. The most common side effects include, but are not limited to, temporary injections site reactions such as redness, pain/tenderness, firmness, swelling, lumps/bumps, bruising, itching, and discoloration. As with all skin injection procedures there is a risk of infection.

Q: Can people with different skin tones be treated with JUVEDERM?

A. Yes. In fact, Juvederm injectable gel is the first FDA-approved hyaluronic acid dermal filler that has proven its safety and effectiveness in persons of color. Studies with Juvederm showed no increased risk of hyperpigmentation or hypertrophic scarring in patients of color.

Q: What should be done prior to treatment?

A. Avoid taking aspirin or ibuprofen both of which can increase bleeding or bruising at the injection site.

Q: What should I do immediately after treatment?

A. Refrain from vigorous exercise until the following day, other than that you can return to your normal activities.

Post-treatment Considerations

Your healthcare professional will tell you what to expect following treatment with Juvederm injectable gel. You should ask your healthcare professional when makeup may be applied after your treatment.

You should avoid the following for at least 24 hours after treatment:

  • Strenuous exercise
  • Consumption of alcoholic beverages
  • Extended exposure to sun or heat

Exposure to any of the above may cause temporary redness, swelling, and/or itching at the injection sites. If there is swelling, you may need to place an ice pack over the swollen area. Be sure to report any redness and/or visible swelling that lasts for more than a few days or any other symptoms that cause you concern to your healthcare professional.

Other Considerations

  • Patients who are using substances that can prolong bleeding, such as aspirin or ibuprofen, as with any injection, may experience increased bruising or bleeding at the injection site. You should inform your healthcare professional before treatment if you are using these types of substances.
  • If laser treatment, chemical peeling, or any other procedure based on active dermal response is considered after treatment with Juvederm injectable gel, there is a possible risk of an inflammatory reaction at the treatment site.
  • Juvederm injectable gel should be used with caution in patients on immunosuppressive therapy, or therapy used to decrease the body's immune response, as there may be an increased risk of infection.
  • The safety of Juvederm injectable gel for use during pregnancy, in breastfeeding females, or in patients under 18 years has not been established.